أعرض في EDS

PF603 FASTER & SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PTS TREATED WITH DARATUMUMAB, LENALIDOMIDE & DEXAMETHASONE (D-RD) VS RD: MAIA

التفاصيل البيبلوغرافية
العنوان: PF603 FASTER & SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PTS TREATED WITH DARATUMUMAB, LENALIDOMIDE & DEXAMETHASONE (D-RD) VS RD: MAIA
المؤلفون: C. McKay, M. Delforge, Shaji Kumar, C. Hulin, Aurore Perrot, Robert Z. Orlowski, Arnaud Jaccard, T. Plesner, C. Chaleteix, P. Mollee, H. Nahi, Saad Z. Usmani, Mikael Roussel, K. Weisel, K. Ramasamy, B. Arnulf, K.S. Gries, R. Kobos, N.J. Bahlis, Lionel Karlin, Ajai Chari, Carla Araujo, J. Trudeau, J. Wang, T. Facon
المصدر: HemaSphere. 3:255
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2019.
سنة النشر: 2019
مصطلحات موضوعية: Health related quality of life, Oncology, medicine.medical_specialty, business.industry, Daratumumab, Hematology, Newly diagnosed, medicine.disease, Transplant ineligible, Internal medicine, medicine, business, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug
تدمد: 2572-9241
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::597d8834ae1073b470e8ba53adfad995Test
https://doi.org/10.1097/01.hs9.0000560700.97828.31Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........597d8834ae1073b470e8ba53adfad995
قاعدة البيانات: OpenAIRE
الوصف
تدمد:25729241